Recaticimab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Recaticimab, covering 2024-12-16 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Vunakizumab Combined With Recaticimab in Subjects With Moderate to Severe Plaque Psoriasis and Dyslipidemia [Phase 4]